Coston McIsaac & Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Buy
885
+2
+0.2% +$31 ﹤0.01% 546
2026
Q1
$11K Buy
883
+2
+0.2% +$28 ﹤0.01% 566
2025
Q4
$10K Sell
881
-75
-8% -$809 ﹤0.01% 579
2025
Q3
$9K Buy
956
+4
+0.4% +$39 ﹤0.01% 564
2025
Q2
$8K Sell
952
-219
-19% -$1.85K ﹤0.01% 561
2025
Q1
$10K Buy
1,171
+6
+0.5% +$63 ﹤0.01% 501
2024
Q4
$14K Sell
1,165
-387
-25% -$4.76K ﹤0.01% 446
2024
Q3
$18K Sell
1,552
-78
-5% -$900 0.01% 412
2024
Q2
$17K Sell
1,630
-309
-16% -$3.41K 0.01% 400
2024
Q1
$23K Sell
1,939
-7
-0.4% -$84 0.01% 370
2023
Q4
$21K Buy
1,946
+10
+0.5% +$96 0.01% 383
2023
Q3
$19K Sell
1,936
-63
-3% -$656 0.01% 384
2023
Q2
$19K Buy
1,999
+10
+0.5% +$96 0.01% 419
2023
Q1
$19K Buy
1,989
+103
+5% +$1.14K 0.01% 409
2022
Q4
$20K Buy
1,886
+9
+0.5% +$94 0.01% 406
2022
Q3
$15K Buy
1,877
+10
+0.5% +$98 0.01% 378
2022
Q2
$20K Buy
+1,867
New +$20.5K 0.01% 211

Other funds holding VTRS

Coston McIsaac & Partners's VTRS Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Viatris (VTRS) stake by 0.23% in Q2 2026, buying an estimated $31 and bringing the position to 885 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Coston McIsaac & Partners first reported a position in VTRS in Q2 2022 and has held it in 17 quarters since. The position peaked at $23K in Q1 2024. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Coston McIsaac & Partners held 885 shares of Viatris worth $14K as of Q2 2026.
  • Coston McIsaac & Partners bought 2 Viatris shares in Q2 2026, an estimated $31.
  • Viatris made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #546 holding.
  • Coston McIsaac & Partners first reported a position in Viatris in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's Viatris position peaked at $23K in Q1 2024.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.